--()--Reval:
“OTC Derivatives Reform and Addressing Systemic Risk.”
|
Who: |
Jiro Okochi, chief executive officer and co-founder of Reval, a derivative risk |
|||
|
management and hedge accounting company which helps over 375 public |
||||
| companies manage and account for the OTC derivatives they use to hedge | ||||
| specific business risks in interest rates, foreign exchange and commodities. | ||||
|
What: |
Will testify before the U.S. Senate Committee on Agriculture, Nutrition, and | |||
|
Forestry in a hearing on “OTC Derivatives Reform and Addressing Systemic Risk.” See |
||||
|
When: |
Wednesday, December 2, 2009 from 9:30 am to 11:30 am ET | |||
|
Where: |
216 Hart Senate Office Building, Washington, DC; see map at | |||
|
http://www.visitthecapitol.gov/Visit/Capitol%20Complex%20Map/ |
||||
|
PR Contact: |
For interviews with Jiro Okochi following the hearing, please contact Zoe Sochor at |
|||
|
zoe.sochor@reval.com, +1 860 799 7076 |
||||
